Current Medical Research and Opinion, Volume 22, Issue 5 (2006)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Current Medical Research and Opinion, Volume 22, Issue 5 (2006)

See all volumes and issues
Vol 40, 2024 Vol 39, 2023 Vol 38, 2022 Vol 37, 2021 Vol 36, 2020 Vol 35, 2019 Vol 34, 2018 Vol 33, 2017 Vol 32, 2016 Vol 31, 2015 Vol 30, 2014 Vol 29, 2013 Vol 28, 2012 Vol 27, 2011 Vol 26, 2010 Vol 25, 2009 Vol 24, 2008 Vol 23, 2007 Volume 22, 2006 Vol 21, 2005 Vol 20, 2004 Vol 19, 2003 Vol 18, 2002 Vol 17, 2001 Vol 16, 2000 Vol 15, 1999 Vol 14, 1997-1998 Vol 13, 1992-1997 Vol 12, 1990-1992 Vol 11, 1988-1990 Vol 10, 1986-1988 Vol 9, 1984-1985 Vol 8, 1982-1984 Vol 7, 1980-1982 Vol 6, 1979-1980 Vol 5, 1977-1979 Vol 4, 1976-1977 Vol 3, 1975-1976 Vol 2, 1974-1975 Vol 1, 1972-1973
Download citations Download PDFs Download issue

Original Article

Article
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:an efficacy and cost-effectiveness study
Mikael Lundborg, Sören Wille, Leif Bjermer, Björn Tilling, Michael Lundgren, Gunilla Telg, Tommy Ekström & Olof Selroos
Pages: 809-821
Published online: 23 Mar 2006
AbstractforMaintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:an efficacy and cost-effectiveness study | References | PDF (448.2 KB)
  • 351 Views
  • 47 CrossRef citations
  • 0Altmetric
Article
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis
Leiv Ose, Arvind Shah, Michael J. Davies, Jennifer Rotonda, Darbie Maccubbin, Diane Tribble, Enrico Veltri & Yale Mitchel
Pages: 823-835
Published online: 23 Mar 2006
AbstractforConsistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis | References | PDF (556.3 KB)
  • 143 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia
Frank J. Papatheofanis, R. Scott McKenzie, Samir H. Mody, Robert Y. Suruki & Catherine Tak Piech
Pages: 837-842
Published online: 23 Mar 2006
AbstractforDosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia | References | PDF (279.3 KB)
  • 134 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Pneumonia due to Pseudomonas aeruginosa:the levofloxacin clinical trials experience
Alan M. Tennenberg, Neelam B. Davis, Shu-Chen Wu & James Kahn
Pages: 843-850
Published online: 30 Mar 2006
AbstractforPneumonia due to Pseudomonas aeruginosa:the levofloxacin clinical trials experience | References | PDF (349.9 KB)
  • 185 Views
  • 9 CrossRef citations
  • 0Altmetric

Commentary

Article Commentary
Improving the global management of the neurogenic bladder patient: part II.Future treatment strategies
Pierre Denys, Jacques Corcos, Karel Everaert, Emmanuel Chartier-Kastler, Clare Fowler, Vinay Kalsi, Victor Nitti, Heinrich Schulte-Baukloh & Brigitte Schurch
Pages: 851-860
Published online: 30 Mar 2006
AbstractforImproving the global management of the neurogenic bladder patient: part II.Future treatment strategies | References | PDF (467.7 KB)
  • 75 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Article

Article
Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes
Andrew J. Palmer, Sean Dinneen, James R. Gavin III, Alastair Gray, William H. Herman & Andrew J. Karter
Pages: 861-872
Published online: 04 Apr 2006
AbstractforCost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes | References | PDF (446.6 KB)
  • 284 Views
  • 35 CrossRef citations
  • 0Altmetric
Article
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
Vasilios G. Athyros, Dimitri P. Mikhailidis, Triandafillos P. Didangelos, Olga I. Giouleme, Evangelos N. Liberopoulos, Asterios Karagiannis, Anna I. Kakafika, Konstantinos Tziomalos, Andrew K. Burroughs & Moses S. Elisaf
Pages: 873-883
Published online: 04 Apr 2006
AbstractforEffect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study | References | PDF (445.2 KB)
  • 558 Views
  • 187 CrossRef citations
  • 0Altmetric
Article
Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis
José M. Ponseti, Jamal Azem, José M. Fort, Manuel López-Cano, Ramón Vilallonga, Josep Gamez & Manuel Armengol
Pages: 885-895
Published online: 04 Apr 2006
AbstractforExperience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis | References | PDF (446 KB)
  • 86 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries
Stefan Holmstrom, Patricia Buchholz, John Walt, Jannie Wickstrøm & Mark Aagren
Pages: 897-905
Published online: 05 Apr 2006
AbstractforThe cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries | References | PDF (464.7 KB)
  • 114 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients
C. M. Howles, H. Saunders, V. Alam, P. Engrand, on behalf of the FSh Treatment Guidelines Clinical panel & on behalf of the FSh Treatment Guidelines Clinical panel
Pages: 907-918
Published online: 06 Apr 2006
AbstractforPredictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients | References | PDF (1.3 MB)
  • 334 Views
  • 62 CrossRef citations
  • 0Altmetric

Brief Review

Brief Report
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis
Jun Iwamoto, Tsuyoshi Takeda & Yoshihiro Sato
Pages: 919-928
Published online: 07 Apr 2006
AbstractforEfficacy and safety of alendronate and risedronate for postmenopausal osteoporosis | References | PDF (422.6 KB)
  • 446 Views
  • 36 CrossRef citations
  • 0Altmetric

Original Article

Article
A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6‐month study
A. W. C. Kung, E. G. Pasion, M. Sofiyan, E. M. C. Lau, B. K. Tay, K. S. Lam, K. Wilawan, B. Ongphiphadhanakul & D. Thiebaud
Pages: 929-937
Published online: 12 Apr 2006
AbstractforA comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6‐month study | References | PDF (340.8 KB)
  • 239 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age
Christopher P. Steidle, Vera J. Stecher, Cindy Pace, Li-Jung Tseng, on behalf of the SEAr Study Group & on behalf of the SEAr Study Group
Pages: 939-948
Published online: 21 Mar 2006
AbstractforCorrelation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age | References | PDF (356.3 KB)
  • 95 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study
Thomas W. Weiss, Deborah T. Gold, Stuart L. Silverman & Colleen A. McHorney
Pages: 949-960
Published online: 12 Apr 2006
AbstractforAn evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study | References | PDF (341.5 KB)
  • 113 Views
  • 32 CrossRef citations
  • 0Altmetric
Article
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes
Lizheng Shi, Rodrigo Juarez, Jodi Hackworth, Eric T. Edgell, Josep Maria Haro, Eduard Vieta & Mauricio F. Tohen
Pages: 961-966
Published online: 13 Apr 2006
AbstractforOpen-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes | References | PDF (265.7 KB)
  • 84 Views
  • 9 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
Craig J. Currie, Phil McEwan, Chris Poole, William J. Valentine, Andrew J. Palmer, Morten Lammert, Lars Nicklasson, Volker Foos & Stéphane Roze
Pages: 967-969
Published online: 19 Apr 2006
First Page PreviewforComments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting | References | PDF (177.6 KB)
  • 259 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost
David Covert & Alan L. Robin
Pages: 971-976
Published online: 19 Apr 2006
AbstractforAdjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost | References | PDF (234.6 KB)
  • 102 Views
  • 40 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac – an Indian experience
A. Pareek, A. S. Chandanwale, J. Oak, U. K. Jain & S. Kapoor
Pages: 977-988
Published online: 19 Apr 2006
AbstractforEfficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac – an Indian experience | References | PDF (548.3 KB)
  • 232 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002
Don Robinson Jr., Monica Hackett, John Wong, Alexa B. Kimball, Russell Cohen, Mohan Bala & for the IMID Study Group
Pages: 989-1000
Published online: 19 Apr 2006
AbstractforCo-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002 | References | PDF (469.5 KB)
  • 477 Views
  • 84 CrossRef citations
  • 0Altmetric
Article
International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH
Andreas Sashegyi, Benjamin L. Trzaskoma, David R. Nelson, Mark D. Williams & William Macias
Pages: 1001-1012
Published online: 19 Apr 2006
AbstractforInternational INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH | References | PDF (469.7 KB)
  • 26 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications
Maike C. Eppens, Maria E. Craig, Timothy W. Jones, Martin Silink, Stephanie Ong, Yeo Jing Ping, on behalf of the international diabetes Federation Western pacific region Steering Committee & on behalf of the international diabetes Federation Western pacific region Steering Committee
Pages: 1013-1020
Published online: 19 Apr 2006
AbstractforType 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications | References | PDF (272.9 KB)
  • 243 Views
  • 52 CrossRef citations
  • 0Altmetric

Explore articles